BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 11175795)

  • 1. Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse.
    Di Cristofano A; De Acetis M; Koff A; Cordon-Cardo C; Pandolfi PP
    Nat Genet; 2001 Feb; 27(2):222-4. PubMed ID: 11175795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A critical role for p27kip1 gene dosage in a mouse model of prostate carcinogenesis.
    Gao H; Ouyang X; Banach-Petrosky W; Borowsky AD; Lin Y; Kim M; Lee H; Shih WJ; Cardiff RD; Shen MM; Abate-Shen C
    Proc Natl Acad Sci U S A; 2004 Dec; 101(49):17204-9. PubMed ID: 15569926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction effect of PTEN and CDKN1B chromosomal regions on prostate cancer linkage.
    Xu J; Langefeld CD; Zheng SL; Gillanders EM; Chang BL; Isaacs SD; Williams AH; Wiley KE; Dimitrov L; Meyers DA; Walsh PC; Trent JM; Isaacs WB
    Hum Genet; 2004 Aug; 115(3):255-62. PubMed ID: 15185141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells.
    Li DM; Sun H
    Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15406-11. PubMed ID: 9860981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTEN expression is reduced in a subset of sporadic thyroid carcinomas: evidence that PTEN-growth suppressing activity in thyroid cancer cells mediated by p27kip1.
    Bruni P; Boccia A; Baldassarre G; Trapasso F; Santoro M; Chiappetta G; Fusco A; Viglietto G
    Oncogene; 2000 Jun; 19(28):3146-55. PubMed ID: 10918569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased AKT activity contributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27Kip1 expression.
    Graff JR; Konicek BW; McNulty AM; Wang Z; Houck K; Allen S; Paul JD; Hbaiu A; Goode RG; Sandusky GE; Vessella RL; Neubauer BL
    J Biol Chem; 2000 Aug; 275(32):24500-5. PubMed ID: 10827191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined loss of PTEN and p27 expression is associated with tumor cell proliferation by Ki-67 and increased risk of recurrent disease in localized prostate cancer.
    Halvorsen OJ; Haukaas SA; Akslen LA
    Clin Cancer Res; 2003 Apr; 9(4):1474-9. PubMed ID: 12684422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of the cyclin-dependent kinase inhibitor p27(Kip1) protein in human prostate cancer correlates with tumor grade.
    Guo Y; Sklar GN; Borkowski A; Kyprianou N
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2269-74. PubMed ID: 9815624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway.
    Sun H; Lesche R; Li DM; Liliental J; Zhang H; Gao J; Gavrilova N; Mueller B; Liu X; Wu H
    Proc Natl Acad Sci U S A; 1999 May; 96(11):6199-204. PubMed ID: 10339565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells.
    Lu Y; Lin YZ; LaPushin R; Cuevas B; Fang X; Yu SX; Davies MA; Khan H; Furui T; Mao M; Zinner R; Hung MC; Steck P; Siminovitch K; Mills GB
    Oncogene; 1999 Nov; 18(50):7034-45. PubMed ID: 10597304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated Skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival.
    Yang G; Ayala G; De Marzo A; Tian W; Frolov A; Wheeler TM; Thompson TC; Harper JW
    Clin Cancer Res; 2002 Nov; 8(11):3419-26. PubMed ID: 12429629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [PTEN and p27Kip1 have a cooperative role on inhibition proliferation, modulation of cell cycle and inducing apoptosis in prostate cancer PC-3 cell].
    Qiu Z; Sun YH; Xu CL; Wang YT; Gu ZQ; Liu Y
    Zhonghua Wai Ke Za Zhi; 2004 May; 42(10):600-3. PubMed ID: 15265403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of the tumor suppressor gene PTEN marks the transition from intratubular germ cell neoplasias (ITGCN) to invasive germ cell tumors.
    Di Vizio D; Cito L; Boccia A; Chieffi P; Insabato L; Pettinato G; Motti ML; Schepis F; D'Amico W; Fabiani F; Tavernise B; Venuta S; Fusco A; Viglietto G
    Oncogene; 2005 Mar; 24(11):1882-94. PubMed ID: 15674339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis.
    Chen Z; Trotman LC; Shaffer D; Lin HK; Dotan ZA; Niki M; Koutcher JA; Scher HI; Ludwig T; Gerald W; Cordon-Cardo C; Pandolfi PP
    Nature; 2005 Aug; 436(7051):725-30. PubMed ID: 16079851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation-independent stabilization of p27kip1 by the phosphoinositide 3-kinase pathway in glioblastoma cells.
    Brandts CH; Bilanges B; Hare G; McCormick F; Stokoe D
    J Biol Chem; 2005 Jan; 280(3):2012-9. PubMed ID: 15542603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of PTEN in malignant and non-malignant human prostate tissues: comparison with p27 protein expression.
    Fenic I; Franke F; Failing K; Steger K; Woenckhaus J
    J Pathol; 2004 May; 203(1):559-66. PubMed ID: 15095479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of cell cycle arrest and apoptosis in human prostate carcinoma cells by a recombinant adenovirus expressing p27(Kip1).
    Katner AL; Hoang QB; Gootam P; Jaruga E; Ma Q; Gnarra J; Rayford W
    Prostate; 2002 Sep; 53(1):77-87. PubMed ID: 12210483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pten dose dictates cancer progression in the prostate.
    Trotman LC; Niki M; Dotan ZA; Koutcher JA; Di Cristofano A; Xiao A; Khoo AS; Roy-Burman P; Greenberg NM; Van Dyke T; Cordon-Cardo C; Pandolfi PP
    PLoS Biol; 2003 Dec; 1(3):E59. PubMed ID: 14691534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p27(kip1) acts as a downstream effector of and is coexpressed with the beta1C integrin in prostatic adenocarcinoma.
    Fornaro M; Tallini G; Zheng DQ; Flanagan WM; Manzotti M; Languino LR
    J Clin Invest; 1999 Feb; 103(3):321-9. PubMed ID: 9927492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlation of Skp2 and P27kip1 protein expression and clinicopathological features of prostate cancer].
    Zheng XY; Ding W; Xie LP; Chen ZD
    Ai Zheng; 2004 Feb; 23(2):215-8. PubMed ID: 14960249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.